Brief introduction of Shandong Freda Biomedical Co., Ltd.

Huaxi Freda Biomedical Co., Ltd., formerly known as Shandong Freda Biomedical Co., Ltd., was established in 1998. It is a high-tech enterprise jointly funded by Huaxi International Investment Group Co., Ltd. and Shandong Freda Pharmaceutical Group Co., Ltd. The company is fully committed to the research, development, production and sales of sodium hyaluronate (called sodium hyaluronate in medical field) series products. According to different application fields and technical requirements, sodium hyaluronate is divided into medical grade (including eye drops and injection grade), cosmetic grade and edible grade.

Huaxi Freda Biomedical Co., Ltd. strictly follows GMP and ISO900 1 quality system to ensure the reliability and stability of product quality. The company is the first manufacturer in China to obtain the qualification of producing sodium hyaluronate by fermentation (National Medicine Zhunzi F2004000 1), and it is also the only manufacturer in China with the approval number of producing sodium hyaluronate by fermentation (National Medicine Zhunzi H20 1 13379) and passed GMP certification. Injection-grade sodium hyaluronate (API) was produced according to ICH Q7, and the quality reached the standards of European Pharmacopoeia and Japanese Pharmacopoeia. Obtained the EU CEP certificate and the United States DMF registration number, and successfully passed the US FDA on-site audit.

As a natural moisturizing factor, sodium hyaluronate has been widely used in cosmetics and recognized by consumers. The company is the first drafting unit of China cosmetic sodium hyaluronate industry standard. Cosmetic grade sodium hyaluronate products passed the international ECOCERT organic cosmetic raw material certification on 20 1 1. In the process of sodium hyaluronate industrialization, the company constantly carries out revolutionary technological innovation. 20 1 1, the company took the lead in realizing the industrialization of sodium hyaluronate oligomer (nanoHATM) by enzyme digestion in the world. In the same year, nanoHATM was officially listed.

Sodium hyaluronate has been widely used in the food field in developed countries such as the United States and Japan. Oral sodium hyaluronate has beauty beauty, which can improve joints. In 2004, Huaxi Freda Biomedical Co., Ltd. took the lead in launching the registration declaration of sodium hyaluronate as a new resource food in China, and conducted a number of safety tests. In September 2008, it became the first enterprise in China to obtain the production qualification of sodium hyaluronate as a new resource food. 20 1 1, food-grade sodium hyaluronate products have passed the international kosher food certification and halal halal food certification.

The company's sodium hyaluronate products occupy a major market share in China, and are exported to the United States, Japan, Europe and other countries and regions, becoming a global raw material supplier for world-renowned pharmaceutical companies, cosmetics companies and health food companies.